The Relevance of the Cluetrain Manifesto in a Social Media World
A conversation with Doc Searls, Senior Editor of Linux Journal and co-author of The Cluetrain Manifesto, about the relevance of the Manifesto for the pharmaceutical industry in today's social media world. Doc will preview the keynote presentation he plans to make at the upcoming Digital Pharma East conference.
WEGO Health Activists’ View of Social Media Regulation Issues: Highlights from a 2011 survey...
A conversation with Jack Barrette, CEO and Founder of WEGO Health, providing feedback, context and prospective on an updated 2011 WEGO Health survey of
Before You Develop That Healthcare App: What You Should Know About Mobile Platforms
A conversation with Seth Perlman, President, The Lathe, about the importance of choosing the right mobile platform and understanding the pros and cons involved when developing healthcare and pharma related applications.
Understanding the Digital Health Mom
A conversation with Fard Johnmar, founder and president at Enspektos, LLC, about a new report that contains both exciting and sobering news for health organizations seeking to engage mothers via social media, mobile and other technologies.
All About Eve – An iPAD Physician Detailing Platform
Guest Tim Lewis, Director, Interactive|RM Strategy at Abelson Taylor, provides details about eve™, which is his company's sales force-focused detailing platform for the iPAD.
The Physician Value Index: A Framework for Measuring Pharmaceutical Marketing Performance
A conversation with Mark Goldstone and Venkat Gullapalli, MD, Co-CEO, Medikly, about a better way to reach, engage and understand healthcare professionals (HCPs) by gaining insights into the HCP journey through various digital touch points and highlighting how these touch points impact the behaviors and preferences of HCPs and their intent to prescribe.
The Clouds of Social Media Guidance: Are They Parting or Is a Storm Brewing?
Pharmaguy interviews Tracy A. England, Vice President of Social Media Marketing for OpenQ. We discuss comments submitted by the Social Media Compliance Council (SMCC) to the FDA seeking clarification of when a pharmaceutical company is "responsible" for postmarketing reporting when promoting drugs on third-party sites.
What Docs Discuss Online: Will New FDA Guidelines Allow Pharma to Join In?
Pharmaguy interviews Peter Kirk, CEO of Sermo, who talks about the nature and value of physician discussions on Sermo and how pharma can engage docs on social media sites and online discussion boards.
UCB’s State ScoreCards: Helping Epilepsy Patients Lobby Lawmakers for Better Access to Innovative Drugs
Cindie Dilley, Head of New Patient Value Focus at UCB, talks about UCB's State ScoreCards program, which won the 2016 eyeforpharma #efpphilly award for Most Valuable Patient Initiative.
Welcome to the CME Laundromat!
Is Pharma-supported Physician Education Biased?
